Benzinga | Jan 25, 2022 04:37AM EST

Needham Maintains Buy on Medtronic, Lowers Price Target to $128

Needham analyst Mike Matson maintains Medtronic (NYSE:MDT) with a Buy and lowers the price target from $131 to $128.